<SEC-DOCUMENT>0001169245-18-000001-index.html : 20180910 <SEC-HEADER>0001169245-18-000001.hdr.sgml : 20180910 <ACCEPTANCE-DATETIME>20180907180230 ACCESSION NUMBER: 0001169245-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: <ITEMS>06b FILED AS OF DATE: 20180910 DATE AS OF CHANGE: 20180907 EFFECTIVENESS DATE: 20180910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-320911 FILM NUMBER: 181061013 BUSINESS ADDRESS: STREET 1: 4020 AERIAL CENTER PARKWAY STREET 2: SUITE 101 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-535-8861 MAIL ADDRESS: STREET 1: 4020 AERIAL CENTER PARKWAY STREET 2: SUITE 101 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 </SEC-HEADER> <DOCUMENT> <TYPE>D <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> </SEC-DOCUMENT>